AGREEMENT AND PLAN OF MERGER among: RITTER PHARMACEUTICALS, INC., a Delaware corporation; RPG28 MERGER SUB, INC., a Delaware corporation; and QUALIGEN, INC., a Delaware corporation Dated as of January 15, 2020Merger Agreement • January 21st, 2020 • Ritter Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Contract Type FiledJanuary 21st, 2020 Company Industry Jurisdiction
AGREEMENT AND PLAN OF MERGER AND REORGANIZATION by and among MYND ANALYTICS, INC., ATHENA MERGER SUBSIDIARY INC., AND EMMAUS LIFE SCIENCES, INC., Dated as of January 4, 2019Merger Agreement • January 7th, 2019 • Emmaus Life Sciences, Inc. • Blank checks • Delaware
Contract Type FiledJanuary 7th, 2019 Company Industry JurisdictionTHIS AGREEMENT AND PLAN OF MERGER AND REORGANIZATION (this “Agreement”) is made and entered into as of January 4, 2019, by and among MYND ANALYTICS, INC., a Delaware corporation (“Parent”), ATHENA MERGER SUBSIDIARY INC., a Delaware corporation and a direct wholly owned subsidiary of Parent (“Merger Sub”), and EMMAUS LIFE SCIENCES, INC., a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Section 8.14.